212 related articles for article (PubMed ID: 29263843)
1. Workflow optimization of whole genome amplification and targeted panel sequencing for CTC mutation detection.
Liu HE; Triboulet M; Zia A; Vuppalapaty M; Kidess-Sigal E; Coller J; Natu VS; Shokoohi V; Che J; Renier C; Chan NH; Hanft VR; Jeffrey SS; Sollier-Christen E
NPJ Genom Med; 2017; 2():34. PubMed ID: 29263843
[TBL] [Abstract][Full Text] [Related]
2. Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA).
Palmirotta R; Lovero D; Silvestris E; Felici C; Quaresmini D; Cafforio P; Silvestris F
Cancer Genomics Proteomics; 2017; 14(3):173-179. PubMed ID: 28446532
[TBL] [Abstract][Full Text] [Related]
3. An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer.
Faugeroux V; Lefebvre C; Pailler E; Pierron V; Marcaillou C; Tourlet S; Billiot F; Dogan S; Oulhen M; Vielh P; Rameau P; NgoCamus M; Massard C; Laplace-Builhé C; Tibbe A; Taylor M; Soria JC; Fizazi K; Loriot Y; Julien S; Farace F
Eur Urol Oncol; 2020 Aug; 3(4):498-508. PubMed ID: 31412010
[TBL] [Abstract][Full Text] [Related]
4. Correlation Between Circulating Tumor Cell DNA Genomic Alterations and Mesenchymal CTCs or CTC-Associated White Blood Cell Clusters in Hepatocellular Carcinoma.
Wang C; Luo Q; Huang W; Zhang C; Liao H; Chen K; Pan M
Front Oncol; 2021; 11():686365. PubMed ID: 34178679
[TBL] [Abstract][Full Text] [Related]
5. Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications.
Sho S; Court CM; Winograd P; Lee S; Hou S; Graeber TG; Tseng HR; Tomlinson JS
BMC Cancer; 2017 Jul; 17(1):457. PubMed ID: 28666423
[TBL] [Abstract][Full Text] [Related]
6. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.
Kidess-Sigal E; Liu HE; Triboulet MM; Che J; Ramani VC; Visser BC; Poultsides GA; Longacre TA; Marziali A; Vysotskaia V; Wiggin M; Heirich K; Hanft V; Keilholz U; Tinhofer I; Norton JA; Lee M; Sollier-Christen E; Jeffrey SS
Oncotarget; 2016 Dec; 7(51):85349-85364. PubMed ID: 27863403
[TBL] [Abstract][Full Text] [Related]
7. Genomic Analysis of Circulating Tumor Cells at the Single-Cell Level.
Lu S; Chang CJ; Guan Y; Szafer-Glusman E; Punnoose E; Do A; Suttmann B; Gagnon R; Rodriguez A; Landers M; Spoerke J; Lackner MR; Xiao W; Wang Y
J Mol Diagn; 2020 Jun; 22(6):770-781. PubMed ID: 32247862
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of circulating tumor cells using a novel workflow combining the CellSearch
Neumann MH; Schneck H; Decker Y; Schömer S; Franken A; Endris V; Pfarr N; Weichert W; Niederacher D; Fehm T; Neubauer H
Biotechnol Prog; 2017 Jan; 33(1):125-132. PubMed ID: 27126369
[TBL] [Abstract][Full Text] [Related]
9. A novel approach for next-generation sequencing of circulating tumor cells.
Yee SS; Lieberman DB; Blanchard T; Rader J; Zhao J; Troxel AB; DeSloover D; Fox AJ; Daber RD; Kakrecha B; Sukhadia S; Belka GK; DeMichele AM; Chodosh LA; Morrissette JJ; Carpenter EL
Mol Genet Genomic Med; 2016 Jul; 4(4):395-406. PubMed ID: 27468416
[TBL] [Abstract][Full Text] [Related]
10. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M
Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients.
Pestrin M; Salvianti F; Galardi F; De Luca F; Turner N; Malorni L; Pazzagli M; Di Leo A; Pinzani P
Mol Oncol; 2015 Apr; 9(4):749-57. PubMed ID: 25539732
[TBL] [Abstract][Full Text] [Related]
12. Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell Counts.
Shaw JA; Guttery DS; Hills A; Fernandez-Garcia D; Page K; Rosales BM; Goddard KS; Hastings RK; Luo J; Ogle O; Woodley L; Ali S; Stebbing J; Coombes RC
Clin Cancer Res; 2017 Jan; 23(1):88-96. PubMed ID: 27334837
[TBL] [Abstract][Full Text] [Related]
13. Detection of EGFR Mutations in cfDNA and CTCs, and Comparison to Tumor Tissue in Non-Small-Cell-Lung-Cancer (NSCLC) Patients.
Liu HE; Vuppalapaty M; Wilkerson C; Renier C; Chiu M; Lemaire C; Che J; Matsumoto M; Carroll J; Crouse S; Hanft VR; Jeffrey SS; Di Carlo D; Garon EB; Goldman J; Sollier E
Front Oncol; 2020; 10():572895. PubMed ID: 33117705
[TBL] [Abstract][Full Text] [Related]
14. Optimization of a WGA-Free Molecular Tagging-Based NGS Protocol for CTCs Mutational Profiling.
De Luca G; Cardinali B; Del Mastro L; Lastraioli S; Carli F; Ferrarini M; Calin GA; Garuti A; Mazzitelli C; Zupo S; Dono M
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575430
[TBL] [Abstract][Full Text] [Related]
15. Next generation sequencing of glioblastoma circulating tumor cells: non-invasive solution for disease monitoring.
Kolostova K; Pospisilova E; Pavlickova V; Bartos R; Sames M; Pawlak I; Bobek V
Am J Transl Res; 2021; 13(5):4489-4499. PubMed ID: 34150029
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis.
Greene SB; Dago AE; Leitz LJ; Wang Y; Lee J; Werner SL; Gendreau S; Patel P; Jia S; Zhang L; Tucker EK; Malchiodi M; Graf RP; Dittamore R; Marrinucci D; Landers M
PLoS One; 2016; 11(11):e0165089. PubMed ID: 27851748
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of circulating colorectal tumor cells defines genetic signatures for individualized cancer care.
Kong SL; Liu X; Suhaimi NM; Koh KJH; Hu M; Lee DYS; Cima I; Phyo WM; Lee EXW; Tai JA; Foong YM; Vo JH; Koh PK; Zhang T; Ying JY; Lim B; Tan MH; Hillmer AM
Oncotarget; 2017 Sep; 8(40):68026-68037. PubMed ID: 28978093
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases.
Beije N; Helmijr JC; Weerts MJA; Beaufort CM; Wiggin M; Marziali A; Verhoef C; Sleijfer S; Jansen MPHM; Martens JWM
Mol Oncol; 2016 Dec; 10(10):1575-1584. PubMed ID: 28949453
[TBL] [Abstract][Full Text] [Related]
19. Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches.
Laprovitera N; Salamon I; Gelsomino F; Porcellini E; Riefolo M; Garonzi M; Tononi P; Valente S; Sabbioni S; Fontana F; Manaresi N; D'Errico A; Pantaleo MA; Ardizzoni A; Ferracin M
Front Cell Dev Biol; 2021; 9():666156. PubMed ID: 34178989
[TBL] [Abstract][Full Text] [Related]
20. Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer.
Keup C; Storbeck M; Hauch S; Hahn P; Sprenger-Haussels M; Tewes M; Mach P; Hoffmann O; Kimmig R; Kasimir-Bauer S
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
